{"id":34025,"date":"2026-01-24T12:19:28","date_gmt":"2026-01-24T20:19:28","guid":{"rendered":"https:\/\/essential.construction\/news\/roches-genentech-more-than-doubles-north-carolina-facility-investment-to-2b\/"},"modified":"2026-01-24T12:19:28","modified_gmt":"2026-01-24T20:19:28","slug":"roches-genentech-more-than-doubles-north-carolina-facility-investment-to-2b","status":"publish","type":"post","link":"https:\/\/essential.construction\/news\/roches-genentech-more-than-doubles-north-carolina-facility-investment-to-2b\/","title":{"rendered":"Roche\u2019s Genentech more than doubles North Carolina facility investment to $2B"},"content":{"rendered":"<p> [ad_1]<br \/>\n<\/p>\n<div>\n<div class=\"text-to-speech\">\n    <button class=\"text-to-speech__button button\"><br \/>\n        <img decoding=\"async\" class=\"text-to-speech__button__icon\" src=\"https:\/\/www.constructiondive.com\/static\/img\/play.svg?500116090725\" alt=\"-\"><br \/>\n        Listen to the article<br \/>\n        <span class=\"text-to-speech__button__audio-length\">3 min<\/span><br \/>\n    <\/button><\/p>\n<div class=\"text-to-speech__controls\">\n        <audio controls=\"\" class=\"js-text-to-speech\" preload=\"none\"><source src=\"https:\/\/text-to-speech.divecdn.com\/newspost\/810260\/2026-01-23_09.44.34\/roche-genentech-doubles-investment-holly-springs-north-carolina-2-billion.wav\" type=\"audio\/mp3\"><\/source><\/audio><\/p>\n<div class=\"text-to-speech__controls__text\">\n            This audio is auto-generated. Please let us know if you have <a rel=\"nofollow noopener\" href=\"https:\/\/www.constructiondive.com\/contact\/\" target=\"_blank\">feedback<\/a>.\n        <\/div>\n<\/p><\/div>\n<\/div>\n<h3 class=\"standard-heading\"><span><span><span><span><span>Dive Brief:<\/span><\/span><\/span><\/span><\/span><\/h3>\n<ul>\n<li>Genentech, a subsidiary of Roche Group, will <a rel=\"nofollow noopener\" href=\"https:\/\/www.gene.com\/media\/press-releases\/15096\/2026-01-20\/genentech-more-than-doubles-investment-i\" target=\"_blank\">more than double<\/a> its initial investment in an upcoming Holly Springs, North Carolina, biomanufacturing facility to $2 billion, the San Francisco-based company said Tuesday.<\/li>\n<li>The additional capital will allow the company to increase production volume and scale capacity within the facility, as well as create a total of 500 local manufacturing jobs, according to a news release. The plant is set to be operational by 2029.<\/li>\n<li>Genentech initially <a rel=\"nofollow noopener\" href=\"https:\/\/www.gene.com\/media\/press-releases\/15074\/2025-08-25\/genentech-and-roche-break-ground-on-stat\" target=\"_blank\"><span><span><span><span><span><span><span><span>pledged $700 million<\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/a><span><span><span><span><span><span> last year to build the Holly Springs factory, its first on the East Coast. The location is designed to produce weight-loss treatments and other metabolic medicines. Construction on the project began in August.<\/span><\/span><\/span><\/span><\/span><\/span><\/li>\n<\/ul>\n<h3 class=\"standard-heading\"><span><span><span><span><span>Dive Insight:<\/span><\/span><\/span><\/span><\/span><\/h3>\n<p><span><span><span><span><span><span>The expansion is part of a broader <\/span><\/span><\/span><\/span><\/span><\/span><a rel=\"nofollow noopener\" href=\"https:\/\/www.gene.com\/about-us\/investing-in-america\" target=\"_blank\"><span><span><span><span><span><span><span><span>$50 billion commitment<\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/a><span><span><span><span><span><span> from Genentech and Roche to improve their U.S. operational footprint. Pharmaceutical giants such as <\/span><\/span><\/span><\/span><\/span><\/span><a rel=\"nofollow noopener\" href=\"https:\/\/www.manufacturingdive.com\/news\/eli-lilly-build-5-billion-cancer-drug-facility-virginia\/760435\/\" target=\"_blank\"><span><span><span><span><span><span><span><span>Lilly<\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/a><span><span><span><span><span><span> and <\/span><\/span><\/span><\/span><\/span><\/span><a rel=\"nofollow noopener\" href=\"https:\/\/www.manufacturingdive.com\/news\/jj-two-multi-billion-dollar-us-plants-north-carolina-pennsylvania\/809428\/\" target=\"_blank\"><span><span><span><span><span><span><span><span>Johnson &amp; Johnson<\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/a><span><span><span><span><span><span> have made similar pledges over the next five years in response to shifting customer demand as the Trump administration\u2019s tariffs disrupt supply chains, markets and production.<\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n<p><span><span><span><span><span><span>\u201cThis additional investment will create more high-quality jobs, strengthen local partnerships, and ensure a resilient supply of medicines for years to come, allowing us to bring life-changing medicines to patients faster and more reliably,\u201d Genentech CEO Ashley Magargee said in a statement.<\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n<p><span><span><span><span><span><span>The company said it increased its investment due, in part, to the skilled local workforce and strong academic institutions in the Raleigh-Durham area. Holly Springs has rapidly emerged as a national biopharmaceutical hub, attracting investments from <a rel=\"nofollow noopener\" href=\"http:\/\/www.manufacturingdive.com\/news\/jj-earmarks-2-billion-fujifilm-biotechnologies-holly-springs-north-carolina-facility\/758602\/\" target=\"_blank\">Fujifilm <span><span>Diosynth Biotechnologies<\/span><\/span><\/a> and <\/span><\/span><\/span><\/span><\/span><\/span><a rel=\"nofollow noopener\" href=\"https:\/\/www.manufacturingdive.com\/news\/amgen-1b-holly-springs-north-carolina-drug-substance-facility\/735410\/\" target=\"_blank\"><span><span><span><span><span><span><span><span>Amgen<\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/a><span><span><span><span><span><span> in recent years. Genentech\u2019s 700,000-square-foot project will be outfitted with advanced biomanufacturing, automation and digital tools to boost efficiency and sustainability, the company said.<\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n<p><span><span><span><span><span><span>Genentech received a $13.1 million state incentive package for the project, including a job creation grant worth $9.8 million, according to the <a rel=\"nofollow noopener\" href=\"https:\/\/www.commerce.nc.gov\/news\/press-releases\/2025\/05\/12\/governor-stein-announces-genentech-will-build-new-manufacturing-plant-wake-county-creating-400-jobs\" target=\"_blank\">North Carolina Department of Commerce<\/a>. The average salary of the new positions will be about $120,000.<\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n<p><span><span><span><span><span><span>Currently, Roche and Genentech have 13 manufacturing and 15 research and development facilities across the nation, supporting 25,000 employees, according to a news release. As part of their broader U.S. investment plans, they are expanding and upgrading facilities in Kentucky, Indiana, New Jersey, Oregon and California.<\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n<\/p><\/div>\n<p>[ad_2]<br \/>\n<br \/><a href=\"https:\/\/www.constructiondive.com\/news\/roche-genentech-doubles-investment-holly-springs-north-carolina-2-billion\/810260\/\" rel=\"nofollow noopener\" target=\"_blank\">This article was originally posted at Source link <\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>[ad_1] Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive &#8230; <a title=\"Roche\u2019s Genentech more than doubles North Carolina facility investment to $2B\" class=\"read-more\" href=\"https:\/\/essential.construction\/news\/roches-genentech-more-than-doubles-north-carolina-facility-investment-to-2b\/\" aria-label=\"Read more about Roche\u2019s Genentech more than doubles North Carolina facility investment to $2B\">Read more<\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[457],"tags":[],"class_list":["post-34025","post","type-post","status-publish","format-standard","hentry","category-construction-dive","generate-columns","tablet-grid-50","mobile-grid-100","grid-parent","grid-33"],"_links":{"self":[{"href":"https:\/\/essential.construction\/news\/wp-json\/wp\/v2\/posts\/34025","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/essential.construction\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/essential.construction\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/essential.construction\/news\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/essential.construction\/news\/wp-json\/wp\/v2\/comments?post=34025"}],"version-history":[{"count":0,"href":"https:\/\/essential.construction\/news\/wp-json\/wp\/v2\/posts\/34025\/revisions"}],"wp:attachment":[{"href":"https:\/\/essential.construction\/news\/wp-json\/wp\/v2\/media?parent=34025"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/essential.construction\/news\/wp-json\/wp\/v2\/categories?post=34025"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/essential.construction\/news\/wp-json\/wp\/v2\/tags?post=34025"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}